Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting Biotech Investing
Real World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® in Patients with Rett Syndrome Published in Developmental Medicine and Child Neurology Biotech Investing
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak Biotech Investing
Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Biotech Investing
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer Biotech Investing
Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference Biotech Investing
Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors Biotech Investing
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th Biotech Investing
